EpiHeart is a young medical device company dedicated to enable surgical administration of novel cellular and gene therapies. Our first focus is Cardiac Micrograft Therapy, a novel autologous cellular therapy administered during CABG surgery to treat ischemic cardiac scars and heart failure.
Company’s Keywords:
cardiac micrograft therapy, ischemic injury repair, medical device development
<5
<
<2019